Case Study

New

Researchers Show How COVID-19 Virus Triggers Immune Signaling “Storm”

Development of Tri-specific Neutralizing Antibodies for the Treatment of COVID-19

Development of serial internalization antibodies

Development of a novel “imbalanced” CSA bispecific antibody by computational design

Publications

01

Optimization of therapeutic antibodies

02

SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2

03

Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity

Here we describe using humanized llama antibody VHHs against SARS-CoV-2 that would overcome the limitations associated with…

04

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

A promising approach to combat COVID-19 is through the neutralization of SARS-CoV-2 by therapeutic antibodies. Previously, we described…

shape section shape